EUVIMEDEUVIMED entdecken
Crossref

Glyoxylate supplementation ameliorates colitis associated colon cancer progression

Nabendu Murmu, Paramita Ghosh, Akhileshwar Namani, Tapas Patra iD

Journal of Cellular Physiology · 2024-11 · 239 (11)

DOI: 10.1002/jcp.31394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 05.09.2024. Verfasst von Nabendu Murmu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Signal Transduction & Biogenic Amine, Chittaranjan National Cancer Institute, Kolkata, India. Hauptthemen laut MEDLINE: Glyoxylates, Colonic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colon cancer is on the rise in younger adults. Despite multimodal treatment strategies, clinical outcomes in advanced stage colon cancer patients remain poor. Neoadjuvant/adjuvant chemotherapy efficacy is limited due to chemoresistance, toxicity, and negative side effects. Overwhelming evidence supporting the small‐molecule metabolites derived from breakdown of food or microbial sources confer an extensive array of host benefits, including chemo‐preventive role in colon cancer. Our previous study indicated that the introduction of glyoxylate (Glx), an intermediate product of microbial or plant metabolism, exerts a cytotoxic effect in colon cancer cells. This study was designed to evaluate the effects of Glx on colon cancer with molecular insights. For this, we established an AOM/DSS‐induced colitis associated colon cancer model in mice. Supplementation of Glx in vivo reduced colitis associated tumor growth and altered the metabolic characteristics of tumor tissue in mice without initiating any severe liver or renal toxicity. More specifically, intake of glyoxylate accumulated glycine in the colon tissue by elevation of alanine‐glyoxylate transferase (AGXT) activity. Glycine accumulation increased intracellular Ca 2+ concentration via glycine receptor activation and dysregulation of Ca 2+ homeostasis lead to induction of apoptosis that resulted in arresting tumor growth. Interestingly, elevation of AGXT activity or Glx related specific metabolic pathway provides better survival in colon cancer patients. Collectively, our exclusive findings support the exploration of Glx either as a preventive molecule or its inclusion in the treatment regimens for colon cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlyoxylatesColonic NeoplasmsAnimalsMiceHumansApoptosisDietary SupplementsColitisTransaminasesDisease ProgressionCalciumMice, Inbred C57BLGlycineMaleDisease Models, AnimalColon

Stichwörter der Autor:innen

apoptosiscolon cancerenzymeglycineglyoxylatemetabolic pathway

Substanzen

Glyoxylatesglyoxylic acidTransaminasesAlanine-glyoxylate transaminaseCalciumGlycine

Autor:innen und Institutionen

  • Department of Signal Transduction & Biogenic Amine, Chittaranjan National Cancer Institute, Kolkata, India.
  • Department of Biotechnology, Brainware University, Kolkata, India.
  • Department of Molecular Research, Sri Shankara Cancer Hospital and Research Centre, Bangalore, India.

ORCID-Profile: Tapas Patra

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Murmu, N., Ghosh, P., Namani, A., & Patra, T. (2024). Glyoxylate supplementation ameliorates colitis associated colon cancer progression. Journal of Cellular Physiology, 239(11). https://doi.org/10.1002/jcp.31394

Vancouver

Murmu N, Ghosh P, Namani A, Patra T. Glyoxylate supplementation ameliorates colitis associated colon cancer progression. Journal of Cellular Physiology. 2024;239(11). doi:10.1002/jcp.31394

BibTeX
@article{Murmu2024,
  author = {Murmu, Nabendu and Ghosh, Paramita and Namani, Akhileshwar and Patra, Tapas},
  title = {Glyoxylate supplementation ameliorates colitis associated colon cancer progression},
  journal = {Journal of Cellular Physiology},
  year = {2024},
  volume = {239},
  number = {11},
  doi = {10.1002/jcp.31394}
}
Kostenlos starten →